Ningbo David Medical Device Hits Day Low Amid Price Pressure at CNY 11.85

Ningbo David Medical Device Co., Ltd. experienced significant activity on March 23, 2026, with the stock declining by 7.72% and reaching an intraday low of CNY 11.85. This drop is part of a broader trend, as the company has faced challenges over the past week, with a 12.9% decrease, and a 16.14% decline over the past month. In comparison, the China Shanghai Composite index fell by 3.63% on the same day, highlighting Ningbo David's underperformance relative to the broader market. Over the past year, the stock has generated a return of -7.08%, contrasting sharply with the Shanghai Composite's gain of 13.33%. Financial metrics indicate a concerning trajectory for the company, with a negative operating profit growth rate of -8.50% over the last five years and a return on equity of 5.16%. The company's debt-equity ratio stands at -0.49, and it has reported negative results for the last four consecutive quarters. As a small-cap player in the pharmaceuticals and biotechnology sector, Ningbo David continues to face headwinds that have impacted its market position and performance indicators.